BRAF V600E-induced distinct DNA damage response defines the therapeutic potential of p53 activation for TP53 wild-type colorectal cancer.
Tokuyama S, Kato H, Takahashi H, Ueda K, Arita A, Ueda R, Seto H, Sekido Y, Hata T, Hamabe A, Ogino T, Miyoshi N, Uemura M, Matsuoka K, Tsukamoto O, Yamamoto H, Doki Y, Eguchi H, Takashima S.
Tokuyama S, et al. Among authors: arita a.
Carcinogenesis. 2024 Jun 13:bgae040. doi: 10.1093/carcin/bgae040. Online ahead of print.
Carcinogenesis. 2024.
PMID: 38868979